- Healthcare
Helping partners follow-up on COVID-19 one year after hospitalization
By combining advanced market research with scientific data from in-market studies, our platform provides direct, ongoing connectivity between healthcare, study or management personnel, product managers, and patients — and in doing so, supports the overall management of health information from clinical trial to commercial launch.
The RESPOND platform supports community-based clinical research to give diverse underserved and underrepresented communities a voice in clinical research. When the FDA issued their guidance, Enhancing the Diversity of Clinical Trials, recommending broader eligibility and increased enrollment of under-represented populations, our platform had been in use for a number of years by programs at The University of Miami Miller School of Medicine, Buffalo University, and a range of projects with The University of Texas Health Science Center School of Public Health across the state.
©2025 RespondHealth